The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Streptozotocin‐Induced Diabetic Models in Mice and Rats
Open accessAbstract
Streptozotocin (STZ) is an antibiotic that causes pancreatic islet β‐cell destruction and is widely used experimentally to produce a model of type 1 diabetes mellitus (T1DM). Detailed in this article are protocols for producing STZ‐induced insulin deficiency and hyperglycemia in mice and rats. Also described are protocols for creating animal models for type 2 diabetes using STZ. These animals are employed for assessing the pathological consequences of diabetes and for screening potential therapies for the treatment of this condition. © 2021 The Authors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
de Souza, R. J., Mente, A., Maroleanu, A., Cozma, A. I., Ha, V., Kishibe, T., Uleryk, E., Budylowski, P., Schünemann, H., Beyene, J., et al. (2015) · BMJ · doi:10.1136/bmj.h3978 · Cited by 1,424 · cited 1×
“These people show an increased mortality compared with non-diabetic populations, for example, a 28% increase in mortality from coronary heart disease (de Souza et al., 2015).”
BackgroundStreptozotocin-Induced Pancreatic Insulitis: New Model of Diabetes Mellitus
Like, A. A., & Rossini, A. A. (1976) · Science · doi:10.1126/science.180605 · Cited by 979
Diabetogenic action of streptozotocin: relationship of dose to metabolic response
Junod, A., Lambert, A. E., Stauffacher, W., & Renold, A. E. (1969) · Journal of Clinical Investigation · doi:10.1172/jci106180 · Cited by 930
A new rat model of type 2 diabetes: The fat-fed, streptozotocin-treated rat
Reed, M. J., Meszaros, K., Entes, L. J., Claypool, M. D., Pinkett, J. G., Gadbois, T. M., & Reaven, G. M. (2000) · Metabolism · doi:10.1053/meta.2000.17721 · Cited by 848
Studies on the diabetogenic action of streptozotocin
Rakieten, N. (1963) · Medical Entomology and Zoology · Cited by 820
Masiello, P., Broca, C., Gross, R., Roye, M., Manteghetti, M., Hillaire-Buys, D., Novelli, M., & Ribes, G. (1998) · Diabetes · doi:10.2337/diab.47.2.224 · Cited by 781
Zhang, M., Lv, X.-Y., Li, J., Xu, Z.-G., & Chen, L. (2008) · Journal of Diabetes Research · doi:10.1155/2008/704045 · Cited by 667
Deeds, M. C., Anderson, J. M., Armstrong, A. S., Gastineau, D. A., Hiddinga, H. J., Jahangir, A., Eberhardt, N. L., & Kudva, Y. C. (2011) · Laboratory Animals · doi:10.1258/la.2010.010090 · Cited by 605
Modeling type 2 diabetes in rats using high fat diet and streptozotocin
Skovsø, S. (2014) · Journal of Diabetes Investigation · doi:10.1111/jdi.12235 · Cited by 596
Leptin- and Leptin Receptor-Deficient Rodent Models: Relevance for Human Type 2 Diabetes
Wang, B., Chandrasekera, P., & Pippin, J. (2014) · Current Diabetes Reviews · doi:10.2174/1573399810666140508121012 · Cited by 506
Mouse Models of Diabetic Nephropathy
Breyer, M. D., Bo[Combining Diaeresis]ttinger, E., Brosius, F. C., Coffman, T. M., Harris, R. C., Heilig, C. W., & Sharma, K. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004080648 · Cited by 467
Studies on the Diabetogenic Action of Streptozotocin (NSC37917)
Raikieten, N. (1963) · Medical Entomology and Zoology · Cited by 443
Gheibi, S., Kashfi, K., & Ghasemi, A. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.08.098 · Cited by 356
The importance of the Non Obese Diabetic (NOD) mouse model in autoimmune diabetes
Pearson, J. A., Wong, F. S., & Wen, L. (2016) · Journal of Autoimmunity · doi:10.1016/j.jaut.2015.08.019 · Cited by 298
Impact of genetic background on nephropathy in diabetic mice
Gurley, S. B., Clare, S. E., Snow, K. P., Hu, A., Meyer, T. W., & Coffman, T. M. (2006) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00204.2005 · Cited by 286
Streptozotocin-nicotinamide-induced rat model of type 2 diabetes (review)
Ghasemi, A., Khalifi, S., & Jedi, S. (2014) · Acta Physiologica Hungarica · doi:10.1556/aphysiol.101.2014.4.2 · Cited by 274
Kolb, H. (1987) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610030308 · Cited by 259
Light and Electron Microscopy of Lesions in Rats Rendered Diabetic with Streptozotocin
Arison, R. N., Ciaccio, E. I., Glitzer, M. S., Cassaro, J. A., & Pruss, M. P. (1967) · Diabetes · doi:10.2337/diab.16.1.51 · Cited by 245
Studies on Streptozotocin Diabetes
Ganda, O. P., Rossini, A. A., & Like, A. A. (1976) · Diabetes · doi:10.2337/diab.25.7.595 · Cited by 224
Schein, P. S., Cooney, D. A., & Vernon, M. L. (1967) · PubMed · Cited by 189
Increased atherosclerosis in streptozotocin-induced diabetic mice.
Kunjathoor, V. V., Wilson, D. L., & LeBoeuf, R. C. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118604 · Cited by 182
Characteristics of Learning and Memory in Streptozocin-Induced Diabetic Mice
Flood, J. F., Mooradian, A. D., & Morley, J. E. (1990) · Diabetes · doi:10.2337/diab.39.11.1391 · Cited by 180
Genetic Influence of the Streptozotocin-induced Insulitis and Hyperglycemia
Rossini, A. A., Appel, M. C., Williams, R. M., & Like, A. A. (1977) · Diabetes · doi:10.2337/diab.26.10.916 · Cited by 158
Kolb-Bachofen, V., Epstein, S. E., Kiesel, U., & Kolb, H. (1988) · Diabetes · doi:10.2337/diab.37.1.21 · Cited by 157
Animal models of type 2 diabetes with reduced pancreatic β-cell mass
Masiello, P. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.09.007 · Cited by 149
Sexual dimorphism in insulin sensitivity and susceptibility to develop diabetes in rats
Vital, P., Larrieta‐Carrasco, E., & Hiriart, M. (2006) · Journal of Endocrinology · doi:10.1677/joe.1.06596 · Cited by 139
Investigation of insulin resistance in the popularly used four rat models of type-2 diabetes
Chao, P.-D. L., Li, Y., Chang, C.-H., Shieh, J., Cheng, J., & Cheng, K. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.02.084 · Cited by 132
Bonnevie‐Nielsen, V., Steffes, M. W., & Lernmark, Å. (1981) · Diabetes · doi:10.2337/diab.30.5.424 · Cited by 127
Diabetic atherosclerosis mouse models
Wu, K. K., & Huan, Y. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.08.030 · Cited by 123
Donovan, J. F., & Brown, P. (2006) · Current Protocols in Immunology · doi:10.1002/0471142735.im0106s73 · Cited by 114
Paik, S.-G., Michelis, M. A., Kim, Y. T., & Shin, S. (1982) · Diabetes · doi:10.2337/diab.31.8.724 · Cited by 113
Recovery of Islet β-Cell Function in Streptozotocin- Induced Diabetic Mice
Yin, D., Tao, J., Lee, D. D., Shen, J., Hara, M., Lopez, J. P., Kuznetsov, A., Philipson, L. H., & Chong, A. S. (2006) · Diabetes · doi:10.2337/db05-1275 · Cited by 102
Bond, J. S., Failla, M. L., & Unger, D. F. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)82019-5 · Cited by 93
Furman, B. L., Candasamy, M., Bhattamisra, S. K., & Veettil, S. K. (2019) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2019.112264 · Cited by 67
Self-citationGlomerular 20-HETE, EETs, and TGF-β1 in diabetic nephropathy
Luo, P., Zhou, Y., Chang, H.-H., Zhang, J., Seki, T., Wang, C., Inscho, E. W., & Wang, M.-H. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.90613.2008 · Cited by 56
Alternatives to the Streptozotocin-Diabetic Rodent
Yorek, M. A. (2016) · International review of neurobiology · doi:10.1016/bs.irn.2016.03.002 · Cited by 55
Lin, M., Yin, N., Murphy, B. T., Medof, M. E., Segerer, S., Heeger, P. S., & Schröppel, B. (2010) · Diabetes · doi:10.2337/db10-0044 · Cited by 54
Mabley, J. G., Rabinovitch, A., Suarez‐Pinzon, W. L., Haskó, G., Pacher, P., Power, R. F., Southan, G. J., Salzman, A. L., & Szabó, C. (2003) · Molecular Medicine · doi:10.2119/2003-00016.mabley · Cited by 52
Byrne, F., Cheetham, S., Vickers, S., & Chapman, V. (2015) · Journal of Diabetes Research · doi:10.1155/2015/752481 · Cited by 49
Wou, C., Unwin, N. C., Huang, Y., & Roglić, G. (2019) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt.2018.09.04 · Cited by 45
Chan, P., Wong, K., Liu, I.-M., Tzeng, T., Yang, T.-L., & Cheng, J. (2003) · Journal of Hypertension · doi:10.1097/00004872-200304000-00020 · Cited by 44
Usuki, S., Ito, Y., Morikawa, K., Kise, M., Ariga, T., Rivner, M. H., & Yu, R. K. (2007) · Nutrition & Metabolism · doi:10.1186/1743-7075-4-25 · Cited by 41
Lenzen, S. (2017) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2915 · Cited by 35
Mancini, J. E., Ortiz, G., Croxatto, J. O., & Gallo, J. E. (2013) · BMC Ophthalmology · doi:10.1186/1471-2415-13-14 · Cited by 31
Zunino, S. J., Simons, L. F., Sambrook, J., & Gething, M.-J. H. (1994) · PubMed Central · Cited by 8
Cited by
Pyridine: the scaffolds with significant clinical diversity
De, S., Kumar S K, A., Shah, S. K., Kazi, S., Sarkar, N., Banerjee, S., & Dey, S. (2022) · RSC Advances · doi:10.1039/d2ra01571d · Cited by 349
Grattoni, A., Korbutt, G., Tomei, A. A., García, A. J., Pepper, A. R., Stabler, C., Brehm, M., Papas, K., Citro, A., Shirwan, H., et al. (2025) · Nature Reviews Endocrinology · doi:10.1038/s41574-024-01029-0 · Cited by 92
Gerace, D., Zhou, Q., Kenty, J. H.-R., Veres, A., Sintov, E., Wang, X., Boulanger, K. R., Li, H., & Melton, D. A. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100879 · Cited by 88
Sun, B. L., Sun, X., Kempf, C. L., Song, J. H., Casanova, N. G., Camp, S. M., Reyes Hernon, V., Fallon, M., Bime, C., Martin, D. R., et al. (2023) · The FASEB Journal · doi:10.1096/fj.202201972rr · Cited by 35
Tang, Q., Tan, Y., Leng, S., Liu, Q., Zhu, L., & Wang, C. (2024) · Materials Today Bio · doi:10.1016/j.mtbio.2024.101087 · Cited by 11
Metadata
- Authors
- Furman, B. L.
- Venue
- Current Protocols
- Publisher
- Wiley
- Published
- 2021-04
- Volume
- 1
- Issue
- 4
- Pages
- e78-e78
- ISSN
- 2691-1299 (ISSN-L)
- OpenAlex
- W3159422802
- Cited by
- 874
- References
- 45
- FWCI
- 101.68
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.